0

Journal Articles

in Vascular Surgery
 21-40 of 353 Articles
JAMA | 
Editorial |  November 07, 2012 FREE
Measured Drug Effect and Cardiovascular Outcomes in Patients Receiving Platelet P2Y12 Receptor Antagonists:  Clarifying the Time and Place for Intensive Inhibition
Matthew J. Price, MD
JAMA. 2012;308(17):1806-1808. doi:10.1001/jama.2012.34011.
JAMA | 
Original Contribution |  November 07, 2012 FREE
Prevalence of Major Cardiovascular Risk Factors and Cardiovascular Diseases Among Hispanic/Latino Individuals of Diverse Backgrounds in the United States
Martha L. Daviglus, MD, PhD; Gregory A. Talavera, MD, MPH; M. Larissa Avilés-Santa, MD, MPH; et al.
JAMA. 2012;308(17):1775-1784. doi:10.1001/jama.2012.14517.
INCLUDES: , Supplemental Content
JAMA Otolaryngology–Head & Neck Surgery | 
Clinical Problem Solving: Pathology |  November 01, 2012
Pathology Quiz Case 1: Diagnosis
Arch Otolaryngol Head Neck Surg. 2012;138(11):1092. doi:10.1001/archotol.138.11.1092.
JAMA Internal Medicine | 
Perspectives |  October 22, 2012 FREE
An Unmeasured Harm of Screening
Vinay Prasad, MD
Arch Intern Med. 2012;172(19):1442-1443. doi:10.1001/2013.jamainternmed.682.
JAMA | 
Editorial |  October 10, 2012
Public Reporting of PCI Outcomes and Quality of Care:  One Step Forward and New Questions Raised
Mauro Moscucci, MD, MBA
JAMA. 2012;308(14):1478-1479. doi:10.1001/jama.2012.13389.
JAMA | 
Original Contribution |  October 10, 2012 FREE
Association of Public Reporting for Percutaneous Coronary Intervention With Utilization and Outcomes Among Medicare Beneficiaries With Acute Myocardial Infarction
Karen E. Joynt, MD, MPH; Daniel M. Blumenthal, MD, MBA; E. John Orav, PhD; et al.
JAMA. 2012;308(14):1460-1468. doi:10.1001/jama.2012.12922.
INCLUDES: , Supplemental Content
JAMA Surgery | 
Original Article |  October 01, 2012
Initial Experience With Hyperthermic Intraperitoneal Chemotherapy
Olivier Turrini, MD; Eric Lambaudie, MD; Marion Faucher, MD; et al.
Arch Surg. 2012;147(10):919-923. doi:10.1001/archsurg.2012.988.
JAMA Surgery | 
Invited Critique |  September 01, 2012
Could the Endo-first Strategy Really Be Better?
Jason T. Lee, MD
Arch Surg. 2012;147(9):846. doi:10.1001/archsurg.2012.2021.
JAMA Surgery | 
Paper |  September 01, 2012
Outcomes of Open Operation for Aortoiliac Occlusive Disease After Failed Endovascular Therapy
Rachel C. Danczyk, MD; Erica L. Mitchell, MD; Bryan D. Petersen, MD; et al.
Arch Surg. 2012;147(9):841-845. doi:10.1001/archsurg.2012.1649.
JAMA Internal Medicine | 
Perspectives |  August 13, 2012 FREE
“My Mother Was 67 . . . ”
Eric B. Larson, MD, MPH; Janice King
Arch Intern Med. 2012;172(15):1132. doi:10.1001/archinternmed.2012.2568.
JAMA Internal Medicine | 
Invited Commentary |  August 13, 2012
How Drug-Eluting Stents Illustrate Our Health System's Flawed Relationship With Technology:  Comment on “Use of Drug-Eluting Stents as a Function of Predicted Benefit”
Peter W. Groeneveld, MD, MS
Arch Intern Med. 2012;172(15):1152-1153. doi:10.1001/archinternmed.2012.2724.
JAMA Internal Medicine | 
Original Investigation |  August 13, 2012
Use of Drug-Eluting Stents as a Function of Predicted Benefit:  Clinical and Economic Implications of Current Practice
Amit P. Amin, MD, MSc; John A. Spertus, MD, MPH; David J. Cohen, MD, MSc; et al.
Arch Intern Med. 2012;172(15):1145-1152. doi:10.1001/archinternmed.2012.3093.
INCLUDES: , Supplemental Content
JAMA | 
Editorial |  August 01, 2012
Endoscopic Vein-Graft Harvest Is Safe for CABG Surgery
Lawrence J. Dacey, MD, MS
JAMA. 2012;308(5):512-513. doi:10.1001/jama.2012.9079.
JAMA Internal Medicine | 
Editor's Correspondence |  July 09, 2012
Percutaneous Coronary Intervention for Stable Coronary Artery Disease: The Debate Continues
Elvis A. Peter, MD; Nuri I. Akkus, MD; Jai Varma, MD, FSCAI
Arch Intern Med. 2012;172(13):1043-1044. doi:10.1001/archinternmed.2012.1753.
JAMA Internal Medicine | 
Invited Commentary |  June 11, 2012
Routine Periodic Stress Testing in Asymptomatic Patients Following Coronary Revascularization: Is It Worth the Effort?:  Comment on “Exercise Testing in Asymptomatic Patients After Revascularization”
Mark J. Eisenberg, MD, MPH
Arch Intern Med. 2012;172(11):861-863. doi:10.1001/archinternmed.2012.1910.
JAMA Internal Medicine | 
Original Investigation |  June 11, 2012
Exercise Testing in Asymptomatic Patients After Revascularization:  Are Outcomes Altered?
Serge C. Harb, MD; Thomas Cook, MPH, PhD; Wael A. Jaber, MD; et al.
Arch Intern Med. 2012;172(11):854-861. doi:10.1001/archinternmed.2012.1355.
JAMA Internal Medicine | 
Invited Commentary |  June 11, 2012
Activating Primary Percutaneous Coronary Intervention for STEMI That Is Not: The Collateral Damage of Improving Door-to-Balloon Time:  Comment on “Prevalence and Factors Associated With False-Positive ST-Segment Elevation Myocardial Infarction Diagnoses at Primary Percutaneous Coronary Intervention–Capable Centers”
Fouad Bachour, MD; Richard Asinger, MD
Arch Intern Med. 2012;172(11):871. doi:10.1001/archinternmed.2012.1117.
JAMA Internal Medicine | 
Original Investigation |  June 11, 2012
Prevalence and Factors Associated With False-Positive ST-Segment Elevation Myocardial Infarction Diagnoses at Primary Percutaneous Coronary Intervention–Capable Centers:  A Report From the Activate-SF Registry
James M. McCabe, MD; Ehrin J. Armstrong, MD, MSc; Ameya Kulkarni, MD; et al.
Arch Intern Med. 2012;172(11):864-871. doi:10.1001/archinternmed.2012.945.
JAMA Internal Medicine | 
Invited Commentary |  April 23, 2012
Drug-Eluting Stents in ST-Segment Elevation Myocardial Infarction:  Comment on “Drug-Eluting vs Bare-Metal Stents in Primary Angioplasty”
James M. Brophy, MEng, MD, PhD
Arch Intern Med. 2012;172(8):621-622. doi:10.1001/archinternmed.2012.694.
JAMA Internal Medicine | 
Review Article |  April 23, 2012 FREE
Drug-Eluting vs Bare-Metal Stents in Primary Angioplasty:  A Pooled Patient-Level Meta-analysis of Randomized Trials
Giuseppe De Luca, MD, PhD; Maurits T. Dirksen, MD; Christian Spaulding, MD; et al.
Arch Intern Med. 2012;172(8):611-621. doi:10.1001/archinternmed.2012.758.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Dermatology
Observation  |  April 01, 2013
Cutaneous Epithelioid Sarcomalike (Pseudomyogenic) Hemangioendothelioma:  A Little-Known Low-Grade Cutaneous Vascular Neoplasm
Luis Requena, MD; Carlos Santonja, MD; Jose Luis Martinez-Amo, MD; et al.
JAMA Surgery
Original Article  |  December 17, 2012
Concomitant Vascular Reconstruction During Pancreatectomy for Malignant Disease:  A Propensity Score–Adjusted, Population-Based Trend Analysis Involving 10 206 Patients
Mathias Worni, MD; Anthony W. Castleberry, MD; Bryan M. Clary, MD; et al.
JAMA Surgery
Invited Critique  |  December 17, 2012
Show Us the Money:  Comment on “Concomitant Vascular Reconstruction During Pancreatectomy for Malignant Disease”
E. Christopher Ellison, MD
JAMA
JAMA Patient Page  |  March 27, 2013
Treatment of Varicose Veins
Allen Hamdan, MD; Edward H. Livingston, MD; Cassio Lynm, MA
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems